Time for Geriatric Assessments in Cancer Care: William Dale, Mazie Tsang, and John Simmons
GeriPal
SEPTEMBER 7, 2023
So I would say that a lot of the education we received were on cutting edge research and the latest drugs in clinical trials, the latest cellular therapies that are coming out. But I think if I were under normal constraints of the healthcare system, I wouldn’t have that time. Mazie: That’s a really nuanced question.
Let's personalize your content